1. Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs
   Valeria Sanabria Guillen et al, 2023, Breast Cancer Research and Treatment CrossRef
2. Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
   Lucas Porras et al, 2021, Cells CrossRef
3. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma
   Yongwen Luo et al, 2019, Aging CrossRef
4. Antimicrobial Photodynamic Therapy Combined With Antibiotic in the Treatment of Rats With Third-Degree Burns
   Zhanjuan Zhao et al, 2021, Frontiers in Microbiology CrossRef
5. Structure–Activity Relationship of N-Phenylthieno[2,3-b]pyridine-2-carboxamide Derivatives Designed as Forkhead Box M1 Inhibitors: The Effect of Electron-Withdrawing and Donating Substituents on the Phenyl Ring
   César Sebastian Huerta-García et al, 2022, Pharmaceuticals CrossRef
6. Role of miR-10b-5p in the prognosis of breast cancer
   Junmin Wang et al, 2019, PeerJ CrossRef
7. UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer
   Yu-Jin Kim et al, 2020, Frontiers in Oncology CrossRef
8. The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer
   Karan Ulhaka et al, 2021, International Journal of Molecular Sciences CrossRef
9. Targeting of the FOXM1 Oncoprotein by E3 Ligase-Assisted Degradation
   Guoshun Luo et al, 2021, Journal of Medicinal Chemistry CrossRef
10. Identification of Milk Fat Metabolism-Related Pathways of the Bovine Mammary Gland during Mid and Late Lactation and Functional Verification of the ACSL4 Gene
    Yongliang Fan et al, 2020, Genes CrossRef